Pablo Mir

Prevalence and clinical features of LRRK2 mutations in patients with Parkinson’s disease in southern Spain

J. López-Barneo, F. Carrillo, P. Gómez-Garre, 2009, European journal of neurology.

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.

J. J. van Hilten, J. Corvol, S. Kõks, 2024, Movement disorders : official journal of the Movement Disorder Society.

Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesia

P. Wilmes, H. Iwaki, E. Glaab, 2023, medRxiv.